Tournier N - Search Results

1

Biali ME, Auvity S, Cisternino S, Smirnova M, Hacker M, Zeitlinger M, Mairinger S, Tournier N, Bauer M, Langer O. Biali ME, et al. Among authors: tournier n. Mol Pharm. 2023 Nov 6;20(11):5877-5887. doi: 10.1021/acs.molpharmaceut.3c00715. Epub 2023 Oct 26. Mol Pharm. 2023. PMID: 37883694 Free PMC article.

2

[The American opioid overdose crisis: A threat for France?].

Vodovar D, Langrand J, Tournier N, Mégarbane B. Vodovar D, et al. Among authors: tournier n. Rev Med Interne. 2019 Jun;40(6):389-394. doi: 10.1016/j.revmed.2018.10.389. Epub 2018 Nov 11. Rev Med Interne. 2019. PMID: 30429046 French.

3

Preparation and stability of voriconazole eye drop solution.

Dupuis A, Tournier N, Le Moal G, Venisse N. Dupuis A, et al. Among authors: tournier n. Antimicrob Agents Chemother. 2009 Feb;53(2):798-9. doi: 10.1128/AAC.01126-08. Epub 2008 Nov 10. Antimicrob Agents Chemother. 2009. PMID: 19001119 Free PMC article.

4

Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.

Cateau E, Tournier N, Dupuis A, Le Moal G, Venisse N. Cateau E, et al. Among authors: tournier n. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):791-5. doi: 10.1016/j.jpba.2005.04.025. J Pharm Biomed Anal. 2005. PMID: 15927437

5

Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.

Cattelotte J, Tournier N, Rizzo-Padoin N, Schinkel AH, Scherrmann JM, Cisternino S. Cattelotte J, et al. Among authors: tournier n. J Neurochem. 2009 Feb;108(3):767-75. doi: 10.1111/j.1471-4159.2008.05832.x. Epub 2008 Dec 4. J Neurochem. 2009. PMID: 19067785 Free article.

6

Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.

Tournier N, André P, Blondeel S, Rizzo-Padoin N, du Moulinet d'Hardemarre A, Declèves X, Scherrmann JM, Cisternino S. Tournier N, et al. J Pharm Sci. 2009 Dec;98(12):4650-60. doi: 10.1002/jps.21771. J Pharm Sci. 2009. PMID: 19492342

7

Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.

Tournier N, Valette H, Peyronneau MA, Saba W, Goutal S, Kuhnast B, Dollé F, Scherrmann JM, Cisternino S, Bottlaender M. Tournier N, et al. J Nucl Med. 2011 Mar;52(3):415-23. doi: 10.2967/jnumed.110.079608. Epub 2011 Feb 14. J Nucl Med. 2011. PMID: 21321274 Free article.

8

Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.

Tournier N, Declèves X, Saubaméa B, Scherrmann JM, Cisternino S. Tournier N, et al. Curr Pharm Des. 2011;17(26):2829-42. doi: 10.2174/138161211797440203. Curr Pharm Des. 2011. PMID: 21827411 Review.

9

Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.

Tournier N, Cisternino S, Peyronneau MA, Goutal S, Dolle F, Scherrmann JM, Bottlaender M, Saba W, Valette H. Tournier N, et al. Pharm Res. 2012 Sep;29(9):2468-76. doi: 10.1007/s11095-012-0776-7. Epub 2012 May 30. Pharm Res. 2012. PMID: 22644589

10

Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.

Alhaddad H, Cisternino S, Declèves X, Tournier N, Schlatter J, Chiadmi F, Risède P, Smirnova M, Besengez C, Scherrmann JM, Baud FJ, Mégarbane B. Alhaddad H, et al. Among authors: tournier n. Crit Care Med. 2012 Dec;40(12):3215-23. doi: 10.1097/CCM.0b013e318265680a. Crit Care Med. 2012. PMID: 22975888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page